VTYX 241220 3.50P (VTYX241220P3500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

VTYX241220P3500

Watchlist

1.35
0.000.00%

15min DelayTrading Nov 11 14:51 ET

0.00High0.00Low

Intraday

5D
Daily

News

Morgan Stanley Maintains Ventyx Biosciences(VTYX.US) With Hold Rating
Moomoo NewsNov 27 06:31 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Ventyx Biosciences (VTYX)
TipRanksNov 27 06:20 ET · Ratings
Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 43% Over the Past Week
Simply Wall StNov 27 05:12 ET
Neurogene and Ventyx Biosciences Rises After Insider Buying by Executives
Seeking AlphaNov 26 12:15 ET
Insider Purchase: CEO AND PRESIDENT of $VTYX (VTYX) Buys 238,248 Shares
Quiver QuantitativeNov 25 21:15 ET
Ventyx Biosciences CEO Mohan Raju Buys $959,889 in Stock
InvestingNov 25 21:10 ET

Comments

Jaguar8

Oct 15 08:03

NEWS

$Ventyx Biosciences (VTYX.US)$
Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024
Ventyx Biosciences (Nasdaq: VTYX) presented new 52-week results from the Phase 2 trial of VTX002 (tamuzimod) in ulcerative colitis at UEG Week 2024. The late-breaking abstract highlighted high rates of clinical and endoscopic remission among long-term extension (LTE) completers at Week 52. CEO Raju Mohan emphasized the data's reinfo...

Jaguar8

Sep 23 12:35

Ventyx Biosciences Price Target Maintained With a $6.00/Share by HC Wainwright & Co

$Ventyx Biosciences (VTYX.US)$

Stock_Drift

Sep 23 08:00

9/23/24 👀’s on_watchlist. 🚨🚨*not financial advice*

$Nuvve (NVVE.US)$ $Treasure Global (TGL.US)$ $Expion360 (XPON.US)$ $Black Diamond Therapeutics (BDTX.US)$ $Ventyx Biosciences (VTYX.US)$
📊⚡️📊

Jaguar8

Sep 23 07:26

“Sanofi has agreed to make a $27 million strategic investment in the Company at an as-converted price of $3.8243 per share of common stock”

$Ventyx Biosciences (VTYX.US)$

Jaguar8

Sep 23 07:03

NEWS

$Ventyx Biosciences (VTYX.US)$
Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (NASDAQ:VTYX) ("Ventyx"), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Sanofi has agreed to make a $27 million strategic investment in the Company at an as-converted price...